Development of ARPE-19-Equipped Ocular Cell Model for In Vitro Investigation on Ophthalmic Formulations

Development of ARPE-19-Equipped Ocular Cell Model for In Vitro Investigation on Ophthalmic Formulations

Repeated intravitreal (IVT) injections in the treatment of retinal diseases can lead to severe complications. Developing innovative drug delivery systems for IVT administration is crucial to prevent adverse reactions, but requires extensive investigation including the use of different preclinical mo...

Full description

Bibliographic Details
Main Authors: Simona Sapino, Giulia Chindamo, Elena Peira, Daniela Chirio, Federica Foglietta, Loredana Serpe, Barbara Vizio, Marina Gallarate
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Pharmaceutics
Subjects:
in vitro ocular flow cell
intravitreal injections
ARPE-19 scaffold
bevacizumab
drug delivery systems
Online Access:https://www.mdpi.com/1999-4923/15/10/2472

Internet

https://www.mdpi.com/1999-4923/15/10/2472

Similar Items